ME logo

23andMe Holding Co (ME)

Profile

Full Name

23andMe Holding Co.

Ticker Symbol

ME

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

November 23, 2020

Indexes

Not included

Website

http://www.23andme.com

Employees

560

Key Details

Price

$1.25(-1.57%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$219.64M(-26.66% YoY)

Annual EPS

-$28.00(-102.90% YoY)

PE ratio

-

Next earnings date

May 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.25
ME price is $1.25

30-Day Relative Volume

0.03
ME 30-day relative volume is 0.03

Price Performance

Price Most recent change

-1.57%
ME price was down -1.57% on Apr 15, 2025

Price YTD change

-61.54%
ME price is down -61.54% since January 1st

Price 1-year change

-83.97%
ME price is down -83.97% year-on-year

Price 3-year change

-98.24%
ME price is down -98.24% over the past 3 years

Price Range

Price All-time high

$353.00
ME price is currently -99.65% below its historical high of $353.00

Price 3-year low

$0.29
ME price is currently +331.03% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$33.53M
ME market capitalization is $33.53 million

Market cap 3-year change

-97.9%
ME market capitalization is down -97.9% over the past 3 years

Market cap All-time high

$5.80B
ME market capitalization is currently -99.42% below its historical high of $5.80 billion

Market cap sector rank

32.65%
ME market capitalization is higher than 32.65% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+9.47%
ME shares outstanding is up +9.47% year-on-year

Shares Outstanding 3-Year Change

+19.55%
ME shares outstanding is up +19.55% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.06
ME beta is 0.06

200-day SMA

$4.62
ME price is currently -72.93% below its 200-day simple moving average

50-day SMA

$1.73
ME price is currently -27.87% below its 50-day simple moving average

RSI

47.94
ME 14-day relative strength index is 47.94

Volume

0.03
ME 30-day relative volume is 0.03

ATR

$0.27
ME average true range is $0.27

10-day Historical Volatility

558.52%
ME 10-day historical volatility is 558.52%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$219.64M
ME annual revenue is $219.64 million

Revenue Analysts estimate

$260.32M
ME annual revenue is currently -15.63% lower than the consensus analysts' forecast

Revenue 1-year change

-26.66%
ME annual revenue is down -26.66% year-on-year

Revenue Sector rank

65.25%
ME annual revenue is higher than 65.25% of companies in Healthcare sector

EPS

EPS

-$28.00
ME annual earnings per share is -$28.00

EPS Analysts estimate

-
ME annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-102.9%
ME annual earnings per share is down -102.9% year-on-year

EPS Sector rank

5.47%
ME annual earnings per share is higher than 5.47% of companies in Healthcare sector

Profit

Gross profit

$99.38M
ME annual gross profit is $99.38 million

Gross margin

45.25%
ME annual gross profit margin is 45.25%

Operating profit

-$321.36M
ME annual operating income is -$321.36 million

Operating margin

-146.31%
ME annual operating profit margin is -146.31%

Net income

-$666.70M
ME annual net profit is -$666.70 million

Net margin

-303.55%
ME annual net profit margin is -303.55%

Expenses

Total expenses

$540.99M
ME annual total expenses is $540.99 million

Operating expenses

$420.73M
ME annual total operating expenses is $420.73 million

Cost of goods sold

$120.26M
ME annual cost of goods sold is $120.26 million

Selling, general & administrative expenses

$215.37M
ME annual SGA is $215.37 million

Depreciation and amortization

$29.48M
ME annual depreciation & amortization is $29.48 million

Interest expense

-
ME annual interest expense value is unknown

Income tax

$73.00K
ME annual income tax is $73.00 thousand

EBIT & EBITDA

EBIT

-$321.36M
ME annual earnings before interest & taxes is -$321.36 million

EBITDA

-$291.87M
ME annual EBITDA is -$291.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$395.17M
ME annual total assets is $395.17 million

Non current assets

$139.86M
ME annual long term assets is $139.86 million

Current assets

$255.31M
ME annual total current assets is $255.31 million

Cash and cash equivalents

$216.49M
ME annual cash & cash equivalents is $216.49 million

Accounts receivable

$3.32M
ME annual accounts receivable is $3.32 million

Inventory

$12.46M
ME annual inventory is $12.46 million

Liabilities

Total liabilities

$206.65M
ME annual total liabilities is $206.65 million

Long term liabilities

$79.32M
ME annual total long term liabilities is $79.32 million

Current liabilities

$127.33M
ME annual total current liabilities is $127.33 million

Accounts payable

$11.57M
ME annual accounts payable is $11.57 million

Debt

Total debt

$76.52M
ME annual total debt is $76.52 million

Total debt 1-year change

-10.3%
ME annual total debt is down -10.3% year-on-year

Long term debt

$67.84M
ME annual long term debt is $67.84 million

Short term debt

$8.67M
ME annual short term debt is $8.67 million

Equity & Capital

Shareholders equity

$188.52M
ME annual stockholders equity is $188.52 million

Book value

$188.52M
ME annual book value is $188.52 million

Retained earnings

-$2.17B
ME annual retained earnings is -$2.17 billion

Working capital

$127.98M
ME annual working capital is $127.98 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$164.32M
ME annual cash flow from operations is -$164.32 million

Cash from operations 1-year change

+0.65%
ME annual cash flow from operations is up +0.65% year-on-year

Cash from investing

-$9.63M
ME annual cash flow from investing activities is -$9.63 million

Cash from investing 1-year change

+14.85%
ME annual cash flow from investing activities is up +14.85% year-on-year

Cash from financing

$3.58M
ME annual cash flow from financing activities is $3.58 million

Cash from financing 1-year change

-63.34%
ME annual cash flow from financing activities is down -63.34% year-on-year

CAPEX

CAPEX

$9.66M
ME annual capital expenditures is $9.66 million

CAPEX 1-year change

-14.62%
ME annual capital expenditures is down -14.62% year-on-year

Free Cash Flow

Free cash flow

-$173.97M
ME annual free cash flow is -$173.97 million

Free cash flow 1-year change

+1.54%
ME annual free cash flow is up +1.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

45.25%
ME annual gross profit margin is 45.25%

Operating margin

-146.31%
ME annual operating profit margin is -146.31%

Net margin

-303.55%
ME annual net profit margin is -303.55%

ROA & ROE

ROA

-99.67%
ME annual return on assets is -99.67%

ROE

-147.75%
ME annual return on equity is -147.75%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ME price to earnings ratio value is unknown

PE ratio Sector rank

-
ME price to earnings ratio is unknown

PB Ratio

PB ratio

0.53
ME price to book ratio is 0.53

PB ratio Sector rank

31.11%
ME price to book ratio is higher than 31.11% of companies in Healthcare sector

PS Ratio

PS ratio

0.16
ME price to sales ratio is 0.16

PS ratio Sector rank

6.28%
ME price to sales ratio is higher than 6.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$14.73M
ME enterprise value is $14.73 million

Enterprise value Sector rank

28.62%
ME enterprise value is higher than 28.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.08
ME EV/EBITDA is -0.08

EV/EBITDA Sector rank

62.49%
ME EV/EBITDA is higher than 62.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.01
ME annual current ratio is 2.01

Quick ratio

1.91
ME annual quick ratio is 1.91

Leverage

Debt to equity

0.00
ME annual debt to equity ratio is 0.00

Interest coverage ratio

-
ME annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
ME piotroski f-score is 4

Altman Z-Score

-9.34
ME altman z-score is -9.34

Analyst ratings

Recent major analysts updates

Apr 16, 24 Citigroup
Neutral
Aug 10, 23 Citigroup
Buy
May 26, 23 Credit Suisse
Outperform
May 26, 23 Citigroup
Neutral
Nov 29, 22 Berenberg
Buy
Nov 8, 22 Credit Suisse
Outperform
Sep 22, 22 Cowen & Co.
Outperform
Aug 10, 22 Citigroup
Neutral
May 27, 22 Credit Suisse
Outperform
May 27, 22 Citigroup
Neutral

Institutional Ownership

Similar stocks

SHLT logo
SHL Telemedicine (SHLT)
NRXP logo
NRx Pharmaceuticals (NRXP)
Radiopharm Theranostics Limited (RADX)
RBOT logo
Vicarious Surgical (RBOT)
RNXT logo
RenovoRx (RNXT)
ATRA logo
Atara Biotherapeutics (ATRA)
RVPH logo
Reviva Pharmaceuticals Holdings (RVPH)
PIII logo
P3 Health Partners (PIII)
RMTI logo
Rockwell Medical (RMTI)
  • What is the ticker symbol for 23andMe Holding Co?
  • Does 23andMe Holding Co pay dividends?
  • What sector is 23andMe Holding Co in?
  • What industry is 23andMe Holding Co in?
  • What country is 23andMe Holding Co based in?
  • When did 23andMe Holding Co go public?
  • Is 23andMe Holding Co in the S&P 500?
  • Is 23andMe Holding Co in the NASDAQ 100?
  • Is 23andMe Holding Co in the Dow Jones?
  • When was 23andMe Holding Co's last earnings report?
  • When does 23andMe Holding Co report earnings?
  • Should I buy 23andMe Holding Co stock now?

What is the ticker symbol for 23andMe Holding Co?

The ticker symbol for 23andMe Holding Co is NASDAQ:ME

Does 23andMe Holding Co pay dividends?

No, 23andMe Holding Co does not pay dividends

What sector is 23andMe Holding Co in?

23andMe Holding Co is in the Healthcare sector

What industry is 23andMe Holding Co in?

23andMe Holding Co is in the Diagnostics & Research industry

What country is 23andMe Holding Co based in?

23andMe Holding Co is headquartered in United States

When did 23andMe Holding Co go public?

23andMe Holding Co's initial public offering (IPO) was on November 23, 2020

Is 23andMe Holding Co in the S&P 500?

No, 23andMe Holding Co is not included in the S&P 500 index

Is 23andMe Holding Co in the NASDAQ 100?

No, 23andMe Holding Co is not included in the NASDAQ 100 index

Is 23andMe Holding Co in the Dow Jones?

No, 23andMe Holding Co is not included in the Dow Jones index

When was 23andMe Holding Co's last earnings report?

23andMe Holding Co's most recent earnings report was on Jan 28, 2025

When does 23andMe Holding Co report earnings?

The next expected earnings date for 23andMe Holding Co is May 23, 2025

Should I buy 23andMe Holding Co stock now?

As of today, analysts generally recommend a 'Sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page